General Information

General Information

DRAVP ID DRAVPe00720

Peptide Name CPR

Sequence CPFVFLR

Sequence Length 7

UniProt ID No entry found

Source Synthetic construct(derived from the C-terminal sequence of α1-antitrypsin)

Activity Information

Target Organism HIV

Assay

Activity

[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=74.07± 22.84 μM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50=73.98 ± 7.44 μM).

Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity

[Ref.22406118]MT-2 cells:CC50>200 μM.

Binding Target Not found

Mechanism The cyclic peptide inhibited HIV-1 infection by blocking virus fusion with and entry into the target cells.

Structure Information

PDB ID None

Predicted Structure Download DRAVPe00720

Linear/Cyclic Cyclic

N-terminal Modification Cyclization (N termini to C termini)

C-terminal Modification Cyclization (N termini to C termini)

Other Modification None

Stereochemistry L

Physicochemical Information

Formula C43H64N10O8S

Absent amino acids ADEGHIKMNQSTWY

Common amino acids F

Mass 881.1

Pl 8.25

Basic residues 1

Acidic residues 0

Hydrophobic residues 4

Net charge 1

Boman Index 128

Hydrophobicity 142.86

Aliphatic Index 97.14

Half Life

Mammalian:1.2 hour
Yeast:>20 hour
E.coli:>10 hour

Extinction Coefficient cystines 0

Absorbance 280nm 0

Polar residues 1

Literature Information

Literature 1

Title Short cyclic peptides derived from the C-terminal sequence of α1-antitrypsin exhibit significant anti-HIV-1 activity.

Pubmed ID 22406118

Reference Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.

Author Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K.

DOI 10.1016/j.bmcl.2012.02.037